<DOC>
	<DOC>NCT00092781</DOC>
	<brief_summary>The purpose of this study is to compare the safety and effectiveness of an investigational drug and an approved drug in the treatment of osteoarthritis of the knee and hip.</brief_summary>
	<brief_title>A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)</brief_title>
	<detailed_description>The duration of treatment is 26 weeks.</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Osteoarthritis of the knee or hip which requires treatment with medication for pain relief Any known allergies to the study drugs</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Arcoxia</keyword>
</DOC>